Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Voya

Nomura Small Cap Core Fund Class C (DCCCX)

Ticker DCCCX · · Holdings as of May 29, 2026

Expense ratio
1.79%$179/yr per $10k
5-yr return
+5.3%annualized
1-yr return
+2.6%as of Dec 2025
Net assets
$5.5Ball share classes
Holdings
138

Bottom line

Is DCCCX a good fund? The bottom line

DCCCX is the Class C share class of Nomura Small Cap Core Fund, an actively managed small-cap mutual fund from Voya.

Its expense ratio is 1.79% — about $179 a year on every $10,000 invested, more expensive than 91% of small-cap funds we track.

It returned +2.6% over one year, +5.3% a year over five years, +8.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $5.5 billion in net assets and 138 holdings, its largest position is Semtech Corp (4.0%) and the top 10 make up 19.8% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (1.79%)
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What DCCCX invests in

Nomura Small Cap Core Fund seeks long-term capital appreciation.

The Fund invests primarily in stocks of small companies that its investment manager, Delaware Management Company (Manager), believes have a combination of attractive valuations, growth prospects, and strong cash flows. Under normal circumstances, at least 80% of the Funds net assets, plus the amount of any borrowings for investment purposes, will be in investments of small-capitalization companies (80% policy). The Fund considers small-capitalization companies to be companies within the market capitalization range of the Russell 2000 Index at the time of purchase. The Funds 80% policy is nonfundamental and may be changed without shareholder approval. Fund shareholders would be given at least 60 days notice prior to any such change.

From the fund's prospectus (filed Mar 27, 2026).

DCCCX performance

Average annual total returns
1 yr5 yr10 yr
DCCCX+2.6%+5.3%+8.2%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full DCCCX performance history →

What DCCCX costs

On a $10,000 investment, DCCCX's 1.79% expense ratio costs about $179 a year. The prospectus estimates $2,105 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full DCCCX fee table →

DCCCX top 10 holdings

#Holding% of fund
1Semtech Corp SMTC4.04%
2Myr Group Inc MYRG2.02%
3Modine Manufacturing Company MOD1.98%
4Axsome Therapeutics Inc AXSM1.83%
5Travere Therapeutics Inc TVTX1.78%
6Credo Technology Group Holding Ltd CRDO1.76%
7Silicon Laboratories Inc SLAB1.65%
8Ligand Pharmaceuticals Inc LGND1.62%
9Arcosa Inc ACA1.56%
10Esco Technologies Inc ESE1.54%

Source: SEC Form N-PORT, period ended May 29, 2026

The top 10 make up 19.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to DCCCX

More funds like DCCCX →

DCCCX FAQ

What is the expense ratio of DCCCX?
DCCCX's expense ratio is 1.79%, which works out to about $179 a year for every $10,000 invested. The prospectus estimates total costs of $2,105 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is DCCCX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (1.79%); 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does DCCCX hold?
DCCCX's largest holdings are Semtech Corp (4.0%), Myr Group Inc (2.0%), Modine Manufacturing Company (2.0%), Axsome Therapeutics Inc (1.8%), Travere Therapeutics Inc (1.8%). It holds 138 positions in total as of May 29, 2026 (SEC Form N-PORT).
What is DCCCX's 5-year return?
DCCCX returned +5.3% a year over the five years ending Dec 31, 2025, and +8.2% a year over ten years. Past performance does not guarantee future results.
Does DCCCX have a sales load?
No. DCCCX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages DCCCX?
DCCCX is offered by Voya through Delaware Group Equity Funds V.